NS · Healthcare

Vanta Bioscience Ltd (540729)

Healthcare Services

Vanta Bioscience Ltd (540729) is listed on NS in the Healthcare sector. Industry: Healthcare Services. As of 2026-07-10, reported market cap is $180.30M, P/E ratio is 149.12, net margin is -77.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for 540729

Market cap
$180.30M
P/E ratio
149.12
Net margin
-77.2%

Vanta Bioscience Ltd (540729) — FAQ

What is Vanta Bioscience Ltd's market cap?

Vanta Bioscience Ltd (540729) has a reported market cap of $180.30M (data as of 2026-07-10).

What is 540729's P/E ratio?

The price-to-earnings (P/E) ratio for Vanta Bioscience Ltd (540729) is 149.12 (data as of 2026-07-10).

Does Vanta Bioscience Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Vanta Bioscience Ltd (540729). Check the MyAverix Finance app for the latest dividend data.

What sector is Vanta Bioscience Ltd in?

Vanta Bioscience Ltd (540729) is classified in the Healthcare sector (Healthcare Services industry).

What exchange is 540729 listed on?

540729 is listed on NS.

What is Vanta Bioscience Ltd's net margin?

Vanta Bioscience Ltd (540729) reports a net margin of -77.2% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play